The University of Kansas Cancer Center — Kansas City, Kansas

The University of Kansas Cancer Center is a clinical research site located in Kansas City, Kansas, United States 66160.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center has participated in 8 clinical trials with 4 currently active.

Therapeutic areas: AML, AML With Mutated NPM1, Hematologic Malignancy.

Sponsors: Kura Oncology, Inc., Deciphera Pharmaceuticals, LLC, Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center?

The University of Kansas Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center conducted?

The University of Kansas Cancer Center has 8 clinical trials on record, with 4 currently active. Their work covers AML, AML With Mutated NPM1, Hematologic Malignancy.

Is The University of Kansas Cancer Center accredited by Crixeo Health?

Yes — The University of Kansas Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The University of Kansas Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.